Amber-Medsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-08-24
Share capital
760 000,00 PLN
Registered address
ul. Krzemieniecka 60A, 54-613 Wrocław, Poland
Email
Email address current
Electronic delivery address
AE:PL-14713-54506-CCGGS-28

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 6.87mMedianUSD 1.75mAverageUSD 5.00m
Net profit
This companyUSD 292.33kMedianUSD 17.49kAverageUSD 85.24k
Operating costs
This companyUSD 6.55mMedianUSD 1.72mAverageUSD 4.85m
Assets
This companyUSD 3.19mMedianUSD 495.38kAverageUSD 1.71m

Bank accounts

Registered as a VAT taxpayer on 2004-07-02. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Buildings and premises
PLN 28,507

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$9,419
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$9,674
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$8,117

Tenders

No recorded participation in tenders.

National Health Fund (NFZ) contracts

Amber-Med has been an NFZ healthcare provider since 2008. In 2009 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2009
Zaopatrzenie w wyroby medyczne będące przedmiotami ortopedycznymi i środkami pomocniczymiświętokrzyskie1USD 0.00

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Aleksandra Anna Śliz – President of the Management Board

Manner of representation

If the management board is a multi-member management board, the submission of declarations of will on behalf of the company requires the joint action of two members of the management board or one member of the management board jointly with a commercial proxy. In the case of a one-person management board, the company is represented by the President of the Management Board independently.

Ownership

OwnerSharesShare valueStake
760$205,294.44100%

Beneficial owners

Person

Competitors

Name
Cefarm RzeszówS.A.
MybestpharmS.A.
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Vitasp. z o.o.

Change history

DateEvent
2026-07-24PKD change
2018-07-25Address change
2018-07-25PKD change
2016-08-24Entered in the register

FAQ

Last updated: 2026-07-24